Skip to main content
. 2019 Jan 10;19:44. doi: 10.1186/s12885-018-5250-4

Fig. 2.

Fig. 2

Ovarian cancer cells sensitivity to different PARP inhibitors. The half maximal inhibitory concentration (IC50) of different OC cells after treatment with (a) olaparib, (b) niraparib and (c) rucaparib, assessed by clonogenic assays. Data represents the mean ± SEM of triplicates of three independent experiments